Squar Milner Financial Services’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-763
Closed -$96K – 318
2020
Q1
$96K Buy
763
+104
+16% +$15.6K 0.06% 273
2019
Q4
$100K Sell
659
-252
-28% -$34.9K 0.05% 323
2019
Q3
$206K Buy
911
+849
+1,369% +$114K 0.11% 208
2019
Q2
$9K Sell
62
-103
-62% -$14K 0.01% 529
2019
Q1
$23K Hold
165
– – 0.02% 410
2018
Q4
$19K Sell
165
-7
-4% -$876 0.02% 397
2018
Q3
$23K Hold
172
– – 0.02% 398
2018
Q2
$19K Buy
+172
New +$18.6K 0.02% 487

Other funds holding CRL

Squar Milner Financial Services's CRL Position: Q2 2020 in Review

Squar Milner Financial Services sold out of Charles River Laboratories (CRL) in Q2 2020, closing a stake of 763 shares — an estimated $96K sold.

Squar Milner Financial Services first reported a position in CRL in Q2 2018 and held it in 8 quarters. The position peaked at $206K in Q3 2019. 466 funds tracked by Wall St. Rank hold CRL as of Q2 2020.

  • Squar Milner Financial Services reported no remaining Charles River Laboratories position as of Q2 2020 after selling out during the quarter.
  • Squar Milner Financial Services sold 763 Charles River Laboratories shares in Q2 2020, an estimated $96K.
  • Squar Milner Financial Services first reported a position in Charles River Laboratories in Q2 2018 and held it in 8 quarters.
  • Squar Milner Financial Services's Charles River Laboratories position peaked at $206K in Q3 2019.
  • 466 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2020.

Based on Squar Milner Financial Services's 13F filing for Q2 2020, filed 16 Jul 2020.